Metraipolis › archive › dc_17ddec7db786
Diminished Prognostic Value of Interim PET in Hodgkin Lymphoma Treated with Brentuximab Vedotin Plus AVD: A Retrospective Analysis — Europe PMC PMID:42645792
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42645792
- DOI
- 10.3390/hematolrep18040053
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T06:51:22.890Z
- SHA-256 of the archived text
066f29965288ced3a0123fef333481774e666e76ce2b262686efdefd66f99fdb- Stable URL of this page
https://metraipolis.com/documento/dc_17ddec7db786
How to cite
Diminished Prognostic Value of Interim PET in Hodgkin Lymphoma Treated with Brentuximab Vedotin Plus AVD: A Retrospective Analysis — Europe PMC PMID:42645792 — Europe PMC (en), https://europepmc.org/article/MED/42645792 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17ddec7db786 (Metraipolis archive dc_17ddec7db786, sha256 066f29965288ced3a0123fef333481774e666e76ce2b262686efdefd66f99fdb)
BibTeX
@misc{dc17ddec7db786,
title = {Diminished Prognostic Value of Interim PET in Hodgkin Lymphoma Treated with Brentuximab Vedotin Plus AVD: A Retrospective Analysis — Europe PMC PMID:42645792},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42645792},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17ddec7db786; sha256 066f29965288ced3a0123fef333481774e666e76ce2b262686efdefd66f99fdb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42645792. Agents can read the archived copy with the MCP tool read_document.